Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor
Molecular Therapy2014Vol. 22(6), pp. 1211–1220
Citations Over TimeTop 10% of 2014 papers
Ann M. Leen, Sujita Sukumaran, Norihiro Watanabe, Somala Mohammed, Jacqueline M. Keirnan, Ryu Yanagisawa, Usanarat Anurathapan, David A. Rendon, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Juan F. Vera
Related Papers
- → You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy(2020)109 cited
- → Early and Late Toxicities of Chimeric Antigen Receptor T-Cells(2023)10 cited
- → Chimeric antigen receptor-redirected T cells return to the bench(2016)35 cited
- → [Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].(2018)
- → [Advances in Structural Designs of Chimeric Antigen Receptor T Cells--Review].(2022)